{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:36:57Z","timestamp":1790318217821,"version":"4.1.0"},"reference-count":245,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Mycobacterium tuberculosis<\/jats:italic>remains the leading cause of death attributed to a single infectious organism. Bacillus Calmette-Guerin (BCG), the standard vaccine against<jats:italic>M. tuberculosis<\/jats:italic>, is thought to prevent only 5% of all vaccine-preventable deaths due to tuberculosis, thus an alternative vaccine is required. One of the principal barriers to vaccine development against<jats:italic>M. tuberculosis<\/jats:italic>is the complexity of the immune response to infection, with uncertainty as to what constitutes an immunological correlate of protection. In this paper, we seek to give an overview of the immunology of<jats:italic>M. tuberculosis<\/jats:italic>infection, and by doing so, investigate possible targets of vaccine development. This encompasses the innate, adaptive, mucosal and humoral immune systems. Though MVA85A did not improve protection compared with BCG alone in a large-scale clinical trial, the correlates of protection this has revealed, in addition to promising results from candidate such as VPM1002, M72\/ASO1E and H56:IC31 point to a brighter future in the field of TB vaccine development.<\/jats:p>","DOI":"10.1007\/s00281-020-00794-0","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T19:02:52Z","timestamp":1584558172000},"page":"315-331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Towards new TB vaccines"],"prefix":"10.1007","volume":"42","author":[{"given":"Benedict","family":"Brazier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"794_CR1","unstructured":"Global Tuberculosis Report (WHO), (2019) Geneva"},{"issue":"2","key":"794_CR2","first-page":"59","volume":"41","author":"K Keja","year":"1988","unstructured":"Keja K, Chan C, Hayden G, Henderson RH (1988) Expanded programme on immunization. World Health Stat Q 41(2):59\u201363","journal-title":"World Health Stat Q"},{"issue":"11","key":"794_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41577-018-0070-y","volume":"18","author":"M Divangahi","year":"2018","unstructured":"Divangahi M (2018) Are tolerance and training required to end TB? Nat Rev Immunol 18(11):661","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"794_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 271(9):698\u2013702","journal-title":"JAMA."},{"key":"794_CR5","unstructured":"WHO, (2001). Global tuberculosis control. WHO report"},{"issue":"17","key":"794_CR6","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","volume":"291","author":"NE Aronson","year":"2004","unstructured":"Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER et al (2004) Long-term efficacy of BCG vaccine in American Indians and Alaska natives: a 60-year follow-up study. Jama. 291(17):2086\u20132091","journal-title":"Jama."},{"issue":"9871","key":"794_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","volume":"381","author":"MD Tameris","year":"2013","unstructured":"Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S et al (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381(9871):1021\u20131028","journal-title":"Lancet"},{"issue":"25","key":"794_CR8","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","volume":"381","author":"DR Tait","year":"2019","unstructured":"Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B et al (2019) Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 381(25):2429\u20132439","journal-title":"N Engl J Med"},{"key":"794_CR9","first-page":"625","volume":"25","author":"A Calmette","year":"1911","unstructured":"Calmette A, Gu\u00e9rin C (1911) Recherches exp\u00e9rimentales sur la d\u00e9fense de l\u2019organisme contre l\u2019infection tuberculeuse. Ann Inst Pasteur 25:625\u2013641","journal-title":"Ann Inst Pasteur"},{"key":"794_CR10","unstructured":"Camille GR, S. R. The history of BCG: early history, pp. 48\u201358. In: Rosenthal SR (ed). London: J&H Churchill. 1957"},{"issue":"6082","key":"794_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","volume":"2","author":"PD Hart","year":"1977","unstructured":"Hart PD, Sutherland I (1977) BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 2(6082):293\u2013295","journal-title":"Br Med J"},{"issue":"3","key":"794_CR12","first-page":"276","volume":"91","author":"GW Comstock","year":"1976","unstructured":"Comstock GW, Woolpert SF, Livesay VT (1976) Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 91(3):276\u2013280","journal-title":"Public Health Rep"},{"issue":"3","key":"794_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2105\/AJPH.64.3.283","volume":"64","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF (1974) Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 64(3):283\u2013291","journal-title":"Am J Public Health"},{"issue":"Jul","key":"794_CR14","first-page":"1","volume":"72","author":"Tuberculosis Prevention Trial, Madras","year":"1980","unstructured":"Tuberculosis Prevention Trial, Madras (1980) Trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 72(Jul):1\u201374","journal-title":"Indian J Med Res"},{"issue":"4","key":"794_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","volume":"15","author":"GW Comstock","year":"1994","unstructured":"Comstock GW (1994) Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials 15(4):247\u2013276","journal-title":"Control Clin Trials"},{"key":"794_CR16","doi-asserted-by":"crossref","unstructured":"Calmette A.. (1931) Preventive vaccination against tuberculosis with BCG. SAGE Publications","DOI":"10.1001\/jama.1931.02720270060030"},{"issue":"5","key":"794_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","volume":"32","author":"N Ritz","year":"2008","unstructured":"Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N (2008) Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 32(5):821\u2013841","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"794_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/clinids\/20.1.126","volume":"20","author":"TF Brewer","year":"1995","unstructured":"Brewer TF, Colditz GA (1995) Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis 20(1):126\u2013135","journal-title":"Clin Infect Dis"},{"issue":"37","key":"794_CR19","first-page":"1","volume":"17","author":"I Abubakar","year":"2013","unstructured":"Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne J et al (2013) Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis. Health Technol Assess (Winchester, England) 17(37):1","journal-title":"Health Technol Assess (Winchester, England)"},{"issue":"2","key":"794_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2672.2009.04161.x","volume":"107","author":"JO Falkinham 3rd","year":"2009","unstructured":"Falkinham JO 3rd (2009) Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 107(2):356\u2013367","journal-title":"J Appl Microbiol"},{"issue":"4","key":"794_CR21","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.4049\/jimmunol.1000552","volume":"185","author":"S Burl","year":"2010","unstructured":"Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A et al (2010) Delaying bacillus Calmette-Guerin vaccination from birth to 4 1\/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 185(4):2620\u20132628","journal-title":"J Immunol"},{"issue":"3","key":"794_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tube.2013.12.006","volume":"94","author":"HC Poyntz","year":"2014","unstructured":"Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H (2014) Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb) 94(3):226\u2013237","journal-title":"Tuberculosis (Edinb)"},{"issue":"9315","key":"794_CR23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","volume":"359","author":"GF Black","year":"2002","unstructured":"Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC et al (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 359(9315):1393\u20131401","journal-title":"Lancet."},{"issue":"2","key":"794_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","volume":"70","author":"L Brandt","year":"2002","unstructured":"Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R et al (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70(2):672\u2013678","journal-title":"Infect Immun"},{"issue":"30","key":"794_CR25","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1016\/j.vaccine.2014.05.042","volume":"32","author":"ML Barreto","year":"2014","unstructured":"Barreto ML, Pilger D, Pereira SM, Genser B, Cruz AA, Cunha SS et al (2014) Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. Vaccine. 32(30):3759\u20133764","journal-title":"Vaccine."},{"issue":"8","key":"794_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen P, Doherty TM (2005) The success and failure of BCG\u2014implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3(8):656","journal-title":"Nat Rev Microbiol"},{"key":"794_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fimmu.2018.00709","volume":"9","author":"N Gupta","year":"2018","unstructured":"Gupta N, Kumar R, Agrawal B (2018) New players in immunity to tuberculosis: the host microbiome, lung epithelium, and innate immune cells. Front Immunol 9:709","journal-title":"Front Immunol"},{"key":"794_CR28","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.13224.1","volume":"7","author":"EW Meermeier","year":"2018","unstructured":"Meermeier EW, Lewinsohn DM (2018) Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis? F1000Research 7:F1000 Faculty Rev-664","journal-title":"F1000Research"},{"issue":"4","key":"794_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4269\/ajtmh.2012.11-0553","volume":"86","author":"CS Mahan","year":"2012","unstructured":"Mahan CS, Zalwango S, Thiel BA, Malone LL, Chervenak KA, Baseke J et al (2012) Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. Am J Trop Med Hyg 86(4):690\u2013697","journal-title":"Am J Trop Med Hyg"},{"key":"794_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ebiom.2017.06.019","volume":"21","author":"CM Bark","year":"2017","unstructured":"Bark CM, Manceur AM, Malone LL, Nsereko M, Okware B, Mayanja HK et al (2017) Identification of host proteins predictive of early stage Mycobacterium tuberculosis infection. EBioMedicine. 21:150\u2013157","journal-title":"EBioMedicine."},{"issue":"9","key":"794_CR31","doi-asserted-by":"publisher","first-page":"e1006577","DOI":"10.1371\/journal.ppat.1006577","volume":"13","author":"A-K Reuschl","year":"2017","unstructured":"Reuschl A-K, Edwards MR, Parker R, Connell DW, Hoang L, Halliday A et al (2017) Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways. PLoS Pathog 13(9):e1006577","journal-title":"PLoS Pathog"},{"issue":"2","key":"794_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","volume":"167","author":"LL Lu","year":"2016","unstructured":"Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS et al (2016) A functional role for antibodies in tuberculosis. Cell. 167(2):433\u201343.e14","journal-title":"Cell."},{"issue":"11","key":"794_CR33","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni.3298","volume":"16","author":"DI Godfrey","year":"2015","unstructured":"Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB (2015) The burgeoning family of unconventional T cells. Nat Immunol 16(11):1114","journal-title":"Nat Immunol"},{"issue":"2","key":"794_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/gene.2014.77","volume":"16","author":"NB Hall","year":"2015","unstructured":"Hall NB, Igo RP Jr, Malone L, Truitt B, Schnell A, Tao L et al (2015) Polymorphisms in TICAM2 and IL1B are associated with TB. Genes Immun 16(2):127","journal-title":"Genes Immun"},{"issue":"43","key":"794_CR35","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S et al (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci 109(43):17537\u201317542","journal-title":"Proc Natl Acad Sci"},{"key":"794_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addr.2015.11.012","volume":"102","author":"EM Agger","year":"2016","unstructured":"Agger EM (2016) Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates. Adv Drug Deliv Rev 102:73\u201382","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"794_CR37","first-page":"185","volume":"70","author":"R Riley","year":"1959","unstructured":"Riley R, Mills C, Nyka W, Weinstock N, Storey P, Sultan L et al (1959) Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. Am J Hyg 70(2):185\u2013196","journal-title":"Am J Hyg"},{"issue":"2","key":"794_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tube.2011.11.007","volume":"92","author":"D Saini","year":"2012","unstructured":"Saini D, Hopkins GW, Seay SA, Chen C-J, Perley CC, Click EM et al (2012) Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice. Tuberculosis. 92(2):160\u2013165","journal-title":"Tuberculosis."},{"key":"794_CR39","unstructured":"Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R (2011) Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol 2011"},{"issue":"4\u20135","key":"794_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1054\/tuld.2000.0242","volume":"80","author":"J Ferguson","year":"2000","unstructured":"Ferguson J, Schlesinger L (2000) Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis. Tuber Lung Dis 80(4\u20135):173\u2013184","journal-title":"Tuber Lung Dis"},{"issue":"1","key":"794_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4167\/jbv.2009.39.1.1","volume":"39","author":"H-M Lee","year":"2009","unstructured":"Lee H-M, Shin D-M, Jo E-K (2009) Mycobacterium tuberculosis induces the production of tumor necrosis factor-\u03b1, interleukin-6, and CXCL8 in pulmonary epithelial cells through reactive oxygen species-dependent mitogen-activated protein kinase activation. J Bacteriol Virol 39(1):1\u201310","journal-title":"J Bacteriol Virol"},{"issue":"3","key":"794_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.icb.7100037","volume":"85","author":"M Sharma","year":"2007","unstructured":"Sharma M, Sharma S, Roy S, Varma S, Bose M (2007) Pulmonary epithelial cells are a source of interferon-\u03b3 in response to Mycobacterium tuberculosis infection. Immunol Cell Biol 85(3):229\u2013237","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"794_CR43","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1128\/IAI.66.3.1121-1126.1998","volume":"66","author":"Y Lin","year":"1998","unstructured":"Lin Y, Zhang M, Barnes PF (1998) Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 66(3):1121\u20131126","journal-title":"Infect Immun"},{"issue":"5","key":"794_CR44","first-page":"L1289","volume":"292","author":"T Nakanaga","year":"2007","unstructured":"Nakanaga T, Nadel JA, Ueki IF, Koff JL, Shao MX (2007) Regulation of interleukin-8 via an airway epithelial signaling cascade. Am J Phys Lung Cell Mol Phys 292(5):L1289\u2013L1L96","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"5","key":"794_CR45","doi-asserted-by":"publisher","first-page":"e97515","DOI":"10.1371\/journal.pone.0097515","volume":"9","author":"MJ Harriff","year":"2014","unstructured":"Harriff MJ, Cansler ME, Toren KG, Canfield ET, Kwak S, Gold MC et al (2014) Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8+ T cells. PLoS One 9(5):e97515","journal-title":"PLoS One"},{"issue":"2","key":"794_CR46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.152.2.743","volume":"152","author":"CS Hirsch","year":"1994","unstructured":"Hirsch CS, Ellner JJ, Russell DG, Rich EA (1994) Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol 152(2):743\u2013753","journal-title":"J Immunol"},{"issue":"3","key":"794_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.4049\/jimmunol.168.3.1328","volume":"168","author":"M Engele","year":"2002","unstructured":"Engele M, St\u00f6\u03b2el E, Castiglione K, Schwerdtner N, Wagner M, B\u00f6lcskei P et al (2002) Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol 168(3):1328\u20131337","journal-title":"J Immunol"},{"issue":"6","key":"794_CR48","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.4049\/jimmunol.1501612","volume":"196","author":"LE Gleeson","year":"2016","unstructured":"Gleeson LE, Sheedy FJ, Palsson-McDermott EM, Triglia D, O\u2019Leary SM, O\u2019Sullivan MP et al (2016) Cutting edge: Mycobacterium tuberculosis induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication. J Immunol 196(6):2444\u20132449","journal-title":"J Immunol"},{"issue":"4","key":"794_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1165\/rcmb.2008-0219OC","volume":"40","author":"RF Silver","year":"2009","unstructured":"Silver RF, Walrath J, Lee H, Jacobson BA, Horton H, Bowman MR et al (2009) Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv. Am J Respir Cell Mol Biol 40(4):491\u2013504","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"794_CR50","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.4049\/jimmunol.166.7.4604","volume":"166","author":"JC Leemans","year":"2001","unstructured":"Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, Verbon A et al (2001) Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol 166(7):4604\u20134611","journal-title":"J Immunol"},{"issue":"1","key":"794_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/426395","volume":"191","author":"JC Leemans","year":"2005","unstructured":"Leemans JC, Thepen T, Weijer S, Florquin S, Van Rooijen N, Van de Winkel JG et al (2005) Macrophages play a dual role during pulmonary tuberculosis in mice. J Infect Dis 191(1):65\u201374","journal-title":"J Infect Dis"},{"issue":"2","key":"794_CR52","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1128\/IAI.72.2.1147-1149.2004","volume":"72","author":"TM Lasco","year":"2004","unstructured":"Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, McMurray DN et al (2004) Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 72(2):1147\u20131149","journal-title":"Infect Immun"},{"issue":"2","key":"794_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tim.2006.11.009","volume":"15","author":"R Appelberg","year":"2007","unstructured":"Appelberg R (2007) Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol 15(2):87\u201392","journal-title":"Trends Microbiol"},{"issue":"2","key":"794_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2249.2007.03330.x","volume":"148","author":"G Kibiki","year":"2007","unstructured":"Kibiki G, Myers L, Kalambo C, Hoang S, Stoler M, Stroup S et al (2007) Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis. Clin Exp Immunol 148(2):254\u2013259","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"794_CR55","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.humimm.2014.06.020","volume":"75","author":"JN Hilda","year":"2014","unstructured":"Hilda JN, Narasimhan M, Das SD (2014) Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1\u03b1, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains. Hum Immunol 75(8):914\u2013922","journal-title":"Hum Immunol"},{"issue":"3","key":"794_CR56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/clim.1999.4709","volume":"91","author":"M Petrofsky","year":"1999","unstructured":"Petrofsky M, Bermudez LE (1999) Neutrophils from Mycobacterium avium-infected mice produce TNF-\u03b1, IL-12, and IL-1\u03b2 and have a putative role in early host response. Clin Immunol 91(3):354\u2013358","journal-title":"Clin Immunol"},{"issue":"7","key":"794_CR57","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1172\/JCI31097","volume":"117","author":"AR Martineau","year":"2007","unstructured":"Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N et al (2007) Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 117(7):1988\u20131994","journal-title":"J Clin Invest"},{"issue":"5","key":"794_CR58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","volume":"10","author":"DH Goetz","year":"2002","unstructured":"Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10(5):1033\u20131043","journal-title":"Mol Cell"},{"key":"794_CR59","doi-asserted-by":"crossref","unstructured":"Dahl SL, Woodworth JS, Lerche CJ, Cramer EP, Nielsen PR, Moser C et al (2018) Lipocalin-2 functions as inhibitor of innate resistance to Mycobacterium tuberculosis. Front Immunol 9","DOI":"10.3389\/fimmu.2018.02717"},{"issue":"6","key":"794_CR60","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1183\/09031936.00140913","volume":"42","author":"DM Lowe","year":"2013","unstructured":"Lowe DM, Bandara AK, Packe GE, Barker RD, Wilkinson RJ, Griffiths CJ et al (2013) Neutrophilia independently predicts death in tuberculosis. Eur Respir J 42(6):1752\u20131757","journal-title":"Eur Respir J"},{"issue":"7309","key":"794_CR61","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 466(7309):973","journal-title":"Nature."},{"issue":"3","key":"794_CR62","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1128\/IAI.73.3.1744-1753.2005","volume":"73","author":"EB Eruslanov","year":"2005","unstructured":"Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, Orlova MO et al (2005) Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73(3):1744\u20131753","journal-title":"Infect Immun"},{"key":"794_CR63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2015.00508","volume":"6","author":"M Allen","year":"2015","unstructured":"Allen M, Bailey C, Cahatol I, Dodge L, Yim J, Kassissa C et al (2015) Mechanisms of control of Mycobacterium tuberculosis by NK cells: role of glutathione. Front Immunol 6:508","journal-title":"Front Immunol"},{"issue":"6","key":"794_CR64","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/IAI.06018-11","volume":"80","author":"S-J Kee","year":"2012","unstructured":"Kee S-J, Kwon Y-S, Park Y-W, Cho Y-N, Lee S-J, Kim T-J et al (2012) Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection. Infect Immun 80(6):2100\u20132108","journal-title":"Infect Immun"},{"issue":"8","key":"794_CR65","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1086\/323600","volume":"184","author":"F Dieli","year":"2001","unstructured":"Dieli F, Troye-Blomberg M, Ivanyi J, Fourni\u00e9 JJ, Krensky AM, Bonneville M et al (2001) Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by V\u03b39\/V\u03b42 T lymphocytes. J Infect Dis 184(8):1082\u20131085","journal-title":"J Infect Dis"},{"key":"794_CR66","unstructured":"Meraviglia S, El Daker S, Dieli F, Martini F, Martino A (2011) \u03b3\u03b4 T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection. Clin Dev Immunol 2011"},{"issue":"5563","key":"794_CR67","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1126\/science.1068819","volume":"295","author":"Y Shen","year":"2002","unstructured":"Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L et al (2002) Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 295(5563):2255\u20132258","journal-title":"Science."},{"issue":"1","key":"794_CR68","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12271","volume":"264","author":"MC Gold","year":"2015","unstructured":"Gold MC, Napier RJ, Lewinsohn DM (2015) MR 1-restricted mucosal associated invariant T (MAIT) cells in the immune response to M ycobacterium tuberculosis. Immunol Rev 264(1):154\u2013166","journal-title":"Immunol Rev"},{"issue":"3","key":"794_CR69","first-page":"338","volume":"72","author":"J Jiang","year":"2016","unstructured":"Jiang J, Yang B, An H, Wang X, Liu Y, Cao Z et al (2016) Mucosal-associated invariant T cells from patients with tuberculosis exhibit impaired immune response. J Inf Secur 72(3):338\u2013352","journal-title":"J Inf Secur"},{"issue":"3","key":"794_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","volume":"41","author":"A Diefenbach","year":"2014","unstructured":"Diefenbach A, Colonna M, Koyasu S (2014) Development, differentiation, and diversity of innate lymphoid cells. Immunity. 41(3):354\u2013365","journal-title":"Immunity."},{"key":"794_CR71","doi-asserted-by":"crossref","unstructured":"Ardain A, Domingo-Gonzalez R, Das S, Kazer SW, Howard NC, Singh A et al (2019) Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 1","DOI":"10.1038\/s41586-019-1276-2"},{"issue":"3","key":"794_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.smim.2004.02.003","volume":"16","author":"DL Woodland","year":"2004","unstructured":"Woodland DL, Randall TD (2004) Anatomical features of anti-viral immunity in the respiratory tract. Semin Immunol 16(3):163\u2013170","journal-title":"Semin Immunol"},{"issue":"9","key":"794_CR73","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nm1091","volume":"10","author":"JE Moyron-Quiroz","year":"2004","unstructured":"Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S et al (2004) Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 10(9):927\u2013934","journal-title":"Nat Med"},{"issue":"2","key":"794_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/path.1628","volume":"204","author":"T Ulrichs","year":"2004","unstructured":"Ulrichs T, Kosmiadi GA, Trusov V, Jorg S, Pradl L, Titukhina M et al (2004) Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol 204(2):217\u2013228","journal-title":"J Pathol"},{"issue":"11","key":"794_CR75","doi-asserted-by":"publisher","first-page":"e1007337","DOI":"10.1371\/journal.ppat.1007337","volume":"14","author":"SKC Ganchua","year":"2018","unstructured":"Ganchua SKC, Cadena AM, Maiello P, Gideon HP, Myers AJ, Junecko BF et al (2018) Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques. PLoS Pathog 14(11):e1007337","journal-title":"PLoS Pathog"},{"issue":"10","key":"794_CR76","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.4049\/jimmunol.1101377","volume":"187","author":"SA Khader","year":"2011","unstructured":"Khader SA, Guglani L, Rangel-Moreno J, Gopal R, Junecko BA, Fountain JJ et al (2011) IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol 187(10):5402\u20135407","journal-title":"J Immunol"},{"key":"794_CR77","doi-asserted-by":"crossref","unstructured":"Slight SR, Rangel-Moreno J, Gopal R, Lin Y, Junecko BAF, Mehra S et al (2013) CXCR5+ T helper cells mediate protective immunity against tuberculosis. J Clin Invest 123(2)","DOI":"10.1172\/JCI65728"},{"issue":"7","key":"794_CR78","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","volume":"17","author":"CS Klose","year":"2016","unstructured":"Klose CS, Artis D (2016) Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol 17(7):765","journal-title":"Nat Immunol"},{"issue":"7","key":"794_CR79","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni.2053","volume":"12","author":"J Rangel-Moreno","year":"2011","unstructured":"Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L et al (2011) The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 12(7):639","journal-title":"Nat Immunol"},{"issue":"5","key":"794_CR80","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1172\/JCI97508","volume":"128","author":"SA Joosten","year":"2018","unstructured":"Joosten SA, van Meijgaarden KE, Arend SM, Prins C, Oftung F, Korsvold GE et al (2018) Mycobacterial growth inhibition is associated with trained innate immunity. J Clin Invest 128(5):1837\u20131851","journal-title":"J Clin Invest"},{"issue":"3","key":"794_CR81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","volume":"33","author":"J Cros","year":"2010","unstructured":"Cros J, Cagnard N, Woollard K, Patey N, Zhang S-Y, Senechal B et al (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 33(3):375\u2013386","journal-title":"Immunity."},{"issue":"6284","key":"794_CR82","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG et al (2016) Trained immunity: a program of innate immune memory in health and disease. Science 352(6284):aaf1098","journal-title":"Science"},{"key":"794_CR83","doi-asserted-by":"publisher","first-page":"i5170","DOI":"10.1136\/bmj.i5170","volume":"355","author":"JP Higgins","year":"2016","unstructured":"Higgins JP, Soares-Weiser K, L\u00f3pez-L\u00f3pez JA, Kakourou A, Chaplin K, Christensen H et al (2016) Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ. 355:i5170","journal-title":"BMJ."},{"issue":"1\u20132","key":"794_CR84","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann E, Sanz J, Dunn JL, Khan N, Mendon\u00e7a LE, Pacis A et al (2018) BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172(1\u20132):176\u201390.e19","journal-title":"Cell"},{"issue":"1","key":"794_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ni.3048","volume":"16","author":"IM Orme","year":"2015","unstructured":"Orme IM, Robinson RT, Cooper AM (2015) The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol 16(1):57","journal-title":"Nat Immunol"},{"issue":"7493","key":"794_CR86","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature12978","volume":"507","author":"H Liu","year":"2014","unstructured":"Liu H, Moynihan KD, Zheng Y, Szeto GL, Li AV, Huang B et al (2014) Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 507(7493):519","journal-title":"Nature."},{"key":"794_CR87","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1038\/ncomms13894","volume":"7","author":"KL Griffiths","year":"2016","unstructured":"Griffiths KL, Ahmed M, Das S, Gopal R, Horne W, Connell TD et al (2016) Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun 7:13894","journal-title":"Nat Commun"},{"issue":"5","key":"794_CR88","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1172\/JCI40817","volume":"120","author":"LR Antonelli","year":"2010","unstructured":"Antonelli LR, Rothfuchs AG, Gon\u00e7alves R, Roff\u00ea E, Cheever AW, Bafica A et al (2010) Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population. J Clin Invest 120(5):1674\u20131682","journal-title":"J Clin Invest"},{"key":"794_CR89","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","volume":"101","author":"S Sharpe","year":"2016","unstructured":"Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A et al (2016) Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Tuberculosis (Edinb) 101:174\u2013190","journal-title":"Tuberculosis (Edinb)"},{"issue":"7788","key":"794_CR90","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","volume":"577","author":"PA Darrah","year":"2020","unstructured":"Darrah PA, Zeppa JJ, Maiello P, Hackney JA, Wadsworth MH 2nd, Hughes TK et al (2020) Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. 577(7788):95\u2013102","journal-title":"Nature."},{"issue":"4","key":"794_CR91","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","volume":"3","author":"SS Master","year":"2008","unstructured":"Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B et al (2008) Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3(4):224\u2013232","journal-title":"Cell Host Microbe"},{"issue":"12","key":"794_CR92","doi-asserted-by":"publisher","first-page":"8330","DOI":"10.1073\/pnas.102055799","volume":"99","author":"D Kaushal","year":"2002","unstructured":"Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, Ko C et al (2002) Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative \u03c3 factor, SigH. Proc Natl Acad Sci 99(12):8330\u20138335","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"794_CR93","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4049\/jimmunol.167.2.910","volume":"167","author":"EH Noss","year":"2001","unstructured":"Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT et al (2001) Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167(2):910\u2013918","journal-title":"J Immunol"},{"issue":"4","key":"794_CR94","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.4049\/jimmunol.173.4.2660","volume":"173","author":"AJ Gehring","year":"2004","unstructured":"Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH (2004) Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol 173(4):2660\u20132668","journal-title":"J Immunol"},{"issue":"1","key":"794_CR95","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.177.1.422","volume":"177","author":"ND Pecora","year":"2006","unstructured":"Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV (2006) Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 177(1):422\u2013429","journal-title":"J Immunol"},{"key":"794_CR96","doi-asserted-by":"publisher","first-page":"32247","DOI":"10.1038\/srep32247","volume":"6","author":"D Pires","year":"2016","unstructured":"Pires D, Marques J, Pombo JP, Carmo N, Bettencourt P, Neyrolles O et al (2016) Role of cathepsins in Mycobacterium tuberculosis survival in human macrophages. Sci Rep 6:32247","journal-title":"Sci Rep"},{"issue":"8","key":"794_CR97","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.4049\/jimmunol.175.8.5324","volume":"175","author":"K Sendide","year":"2005","unstructured":"Sendide K, Deghmane A-E, Pechkovsky D, Av-Gay Y, Talal A, Hmama Z (2005) Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J Immunol 175(8):5324\u20135332","journal-title":"J Immunol"},{"issue":"1","key":"794_CR98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mib.2008.11.003","volume":"12","author":"R Simeone","year":"2009","unstructured":"Simeone R, Bottai D, Brosch R (2009) ESX\/type VII secretion systems and their role in host\u2013pathogen interaction. Curr Opin Microbiol 12(1):4\u201310","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"794_CR99","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.4049\/jimmunol.1303185","volume":"192","author":"R Madan-Lala","year":"2014","unstructured":"Madan-Lala R, Sia JK, King R, Adekambi T, Monin L, Khader SA et al (2014) Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1. J Immunol 192(9):4263\u20134272","journal-title":"J Immunol"},{"issue":"5","key":"794_CR100","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.chom.2008.03.008","volume":"3","author":"H Bach","year":"2008","unstructured":"Bach H, Papavinasasundaram KG, Wong D, Hmama Z, Av-Gay Y (2008) Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3(5):316\u2013322","journal-title":"Cell Host Microbe"},{"issue":"1","key":"794_CR101","doi-asserted-by":"publisher","first-page":"e8769","DOI":"10.1371\/journal.pone.0008769","volume":"5","author":"J Sun","year":"2010","unstructured":"Sun J, Wang X, Lau A, Liao T-YA, Bucci C, Hmama Z (2010) Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS One 5(1):e8769","journal-title":"PLoS One"},{"issue":"8","key":"794_CR102","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1172\/JCI31947","volume":"117","author":"J Hinchey","year":"2007","unstructured":"Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B et al (2007) Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest 117(8):2279\u20132288","journal-title":"J Clin Invest"},{"issue":"1","key":"794_CR103","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/imr.12268","volume":"264","author":"Z Hmama","year":"2015","unstructured":"Hmama Z, Pe\u00f1a-D\u00edaz S, Joseph S, Av-Gay Y (2015) Immunoevasion and immunosuppression of the macrophage by M ycobacterium tuberculosis. Immunol Rev 264(1):220\u2013232","journal-title":"Immunol Rev"},{"issue":"8","key":"794_CR104","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nm906","volume":"9","author":"UE Schaible","year":"2003","unstructured":"Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K et al (2003) Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 9(8):1039","journal-title":"Nat Med"},{"issue":"6","key":"794_CR105","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/CVI.00015-11","volume":"18","author":"P Johansen","year":"2011","unstructured":"Johansen P, Fettelschoss A, Amstutz B, Selchow P, Waeckerle-Men Y, Keller P et al (2011) Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens. Clin Vaccine Immunol 18(6):907\u2013913","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"794_CR106","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","volume":"33","author":"P Sander","year":"2015","unstructured":"Sander P, Clark S, Petrera A, Vilaplana C, Meuli M, Selchow P et al (2015) Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis. Vaccine. 33(11):1353\u20131359","journal-title":"Vaccine."},{"issue":"7","key":"794_CR107","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","volume":"32","author":"B Khatri","year":"2014","unstructured":"Khatri B, Whelan A, Clifford D, Petrera A, Sander P, Vordermeier HM (2014) BCG \u0394zmp1 vaccine induces enhanced antigen specific immune responses in cattle. Vaccine. 32(7):779\u2013784","journal-title":"Vaccine."},{"issue":"3","key":"794_CR108","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1365-2249.2010.04092.x","volume":"160","author":"M Fujita","year":"2010","unstructured":"Fujita M, Harada E, Matsumoto T, Mizuta Y, Ikegame S, Ouchi H et al (2010) Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease. Clin Exp Immunol 160(3):457\u2013460","journal-title":"Clin Exp Immunol"},{"issue":"2\u20133","key":"794_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0300-9084(02)01369-X","volume":"84","author":"C Fleury","year":"2002","unstructured":"Fleury C, Mignotte B, Vayssi\u00e8re J-L (2002) Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 84(2\u20133):131\u2013141","journal-title":"Biochimie."},{"issue":"4","key":"794_CR110","doi-asserted-by":"publisher","first-page":"e1000864","DOI":"10.1371\/journal.ppat.1000864","volume":"6","author":"JL Miller","year":"2010","unstructured":"Miller JL, Velmurugan K, Cowan MJ, Briken V (2010) The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-\u03b1-mediated host cell apoptosis. PLoS Pathog 6(4):e1000864","journal-title":"PLoS Pathog"},{"issue":"3","key":"794_CR111","doi-asserted-by":"publisher","first-page":"e00679","DOI":"10.1128\/mBio.00679-16","volume":"7","author":"M Gengenbacher","year":"2016","unstructured":"Gengenbacher M, Nieuwenhuizen N, Vogelzang A, Liu H, Kaiser P, Schuerer S et al (2016) Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG \u0394ureC::hly improves protection against tuberculosis. MBio. 7(3):e00679\u2013e00616","journal-title":"MBio."},{"issue":"2","key":"794_CR112","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/653533","volume":"51","author":"DS Kernodle","year":"2010","unstructured":"Kernodle DS (2010) Decrease in the effectiveness of bacille Calmette-Gu\u00e9rin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation. Clin Infect Dis 51(2):177\u2013184","journal-title":"Clin Infect Dis"},{"key":"794_CR113","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1038\/ncomms9533","volume":"6","author":"D Kaushal","year":"2015","unstructured":"Kaushal D, Foreman TW, Gautam US, Alvarez X, Adekambi T, Rangel-Moreno J et al (2015) Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis. Nat Commun 6:8533","journal-title":"Nat Commun"},{"issue":"4","key":"794_CR114","doi-asserted-by":"publisher","first-page":"fty037","DOI":"10.1093\/femspd\/fty037","volume":"76","author":"S Upadhyay","year":"2018","unstructured":"Upadhyay S, Mittal E, Philips J (2018) Tuberculosis and the art of macrophage manipulation. Pathogens Disease 76(4):fty037","journal-title":"Pathogens Disease"},{"issue":"8","key":"794_CR115","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.4049\/jimmunol.179.8.5137","volume":"179","author":"H Soualhine","year":"2007","unstructured":"Soualhine H, Deghmane A-E, Sun J, Mak K, Talal A, Av-Gay Y et al (2007) Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol 179(8):5137\u20135145","journal-title":"J Immunol"},{"issue":"5","key":"794_CR116","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/JB.178.5.1274-1282.1996","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178(5):1274\u20131282","journal-title":"J Bacteriol"},{"issue":"9","key":"794_CR117","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.4161\/auto.20881","volume":"8","author":"A Romagnoli","year":"2012","unstructured":"Romagnoli A, Etna MP, Giacomini E, Pardini M, Remoli ME, Corazzari M et al (2012) ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy. 8(9):1357\u20131370","journal-title":"Autophagy."},{"issue":"5","key":"794_CR118","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nm859","volume":"9","author":"AS Pym","year":"2003","unstructured":"Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A et al (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9(5):533","journal-title":"Nat Med"},{"issue":"11","key":"794_CR119","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","volume":"18","author":"MI Gr\u00f6schel","year":"2017","unstructured":"Gr\u00f6schel MI, Sayes F, Shin SJ, Frigui W, Pawlik A, Orgeur M et al (2017) Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection. Cell Rep 18(11):2752\u20132765","journal-title":"Cell Rep"},{"issue":"9","key":"794_CR120","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","volume":"95","author":"J Hess","year":"1998","unstructured":"Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SH (1998) Mycobacterium bovis bacille Calmette\u2013Gu\u00e9rin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci 95(9):5299\u20135304","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"794_CR121","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI24617","volume":"115","author":"L Grode","year":"2005","unstructured":"Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Eddine AN et al (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115(9):2472\u20132479","journal-title":"J Clin Invest"},{"issue":"8","key":"794_CR122","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tim.2012.04.006","volume":"20","author":"MA Hamon","year":"2012","unstructured":"Hamon MA, Ribet D, Stavru F, Cossart P (2012) Listeriolysin O: the Swiss army knife of Listeria. Trends Microbiol 20(8):360\u2013368","journal-title":"Trends Microbiol"},{"issue":"5","key":"794_CR123","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1462-5822.2005.00665.x","volume":"8","author":"LM Shaughnessy","year":"2006","unstructured":"Shaughnessy LM, Hoppe AD, Christensen KA, Swanson JA (2006) Membrane perforations inhibit lysosome fusion by altering pH and calcium in Listeria monocytogenes vacuoles. Cell Microbiol 8(5):781\u2013792","journal-title":"Cell Microbiol"},{"issue":"7","key":"794_CR124","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1128\/IAI.55.7.1641-1646.1987","volume":"55","author":"C Geoffroy","year":"1987","unstructured":"Geoffroy C, Gaillard J-L, Alouf JE, Berche P (1987) Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun 55(7):1641\u20131646","journal-title":"Infect Immun"},{"key":"794_CR125","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","volume":"8","author":"NE Nieuwenhuizen","year":"2017","unstructured":"Nieuwenhuizen NE, Kulkarni PS, Shaligram U, Cotton MF, Rentsch CA, Eisele B et al (2017) The recombinant bacille Calmette\u2013Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing. Front Immunol 8:1147","journal-title":"Front Immunol"},{"issue":"12","key":"794_CR126","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","volume":"210","author":"A Vogelzang","year":"2014","unstructured":"Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M et al (2014) Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Gu\u00e9rin \u0394 ureC::hly vaccine\u2019s superior protection against tuberculosis. J Infect Dis 210(12):1928\u20131937","journal-title":"J Infect Dis"},{"issue":"5","key":"794_CR127","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1586\/14760584.2014.905746","volume":"13","author":"SH Kaufmann","year":"2014","unstructured":"Kaufmann SH, Cotton MF, Eisele B, Gengenbacher M, Grode L, Hesseling AC et al (2014) The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Rev Vaccines 13(5):619\u2013630","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"794_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/vaccines1020120","volume":"1","author":"K Velmurugan","year":"2013","unstructured":"Velmurugan K, Grode L, Chang R, Fitzpatrick M, Laddy D, Hokey D et al (2013) Nonclinical development of BCG replacement vaccine candidates. Vaccines. 1(2):120\u2013138","journal-title":"Vaccines."},{"issue":"9","key":"794_CR129","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","volume":"31","author":"L Grode","year":"2013","unstructured":"Grode L, Ganoza CA, Brohm C, Weiner J 3rd, Eisele B, Kaufmann SH (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine. 31(9):1340\u20131348","journal-title":"Vaccine."},{"issue":"2","key":"794_CR130","doi-asserted-by":"publisher","first-page":"e00439","DOI":"10.1128\/CVI.00439-16","volume":"24","author":"AG Loxton","year":"2017","unstructured":"Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B et al (2017) Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa. Clin Vaccine Immunol 24(2):e00439\u2013e00416","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"794_CR131","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","volume":"178","author":"JL Flynn","year":"1993","unstructured":"Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178(6):2249\u20132254","journal-title":"J Exp Med"},{"issue":"6","key":"794_CR132","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","volume":"178","author":"AM Cooper","year":"1993","unstructured":"Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178(6):2243\u20132247","journal-title":"J Exp Med"},{"issue":"2","key":"794_CR133","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","volume":"8","author":"A Pawlowski","year":"2012","unstructured":"Pawlowski A, Jansson M, Sk\u00f6ld M, Rottenberg ME, K\u00e4llenius G (2012) Tuberculosis and HIV co-infection. PLoS Pathog 8(2):e1002464","journal-title":"PLoS Pathog"},{"issue":"12","key":"794_CR134","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1089\/aid.2012.0028","volume":"28","author":"PL Lin","year":"2012","unstructured":"Lin PL, Rutledge T, Green AM, Bigbee M, Fuhrman C, Klein E et al (2012) CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques. AIDS Res Hum Retrovir 28(12):1693\u20131702","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"794_CR135","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","volume":"18","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J et al (2006;Elsevier) Inborn errors of IL-12\/23-and IFN-\u03b3-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18(6):347\u2013361","journal-title":"Semin Immunol"},{"issue":"3","key":"794_CR136","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cmi.2017.113","volume":"15","author":"G Zeng","year":"2018","unstructured":"Zeng G, Zhang G, Chen X (2018) Th1 cytokines, true functional signatures for protective immunity against TB? Cell Mol Immunol 15(3):206","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"794_CR137","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","volume":"192","author":"S Sakai","year":"2014","unstructured":"Sakai S, Kauffman KD, Schenkel JM, McBerry CC, Mayer-Barber KD, Masopust D et al (2014) Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma\u2013homing CD4 T cells. J Immunol 192(7):2965\u20132969","journal-title":"J Immunol"},{"issue":"5","key":"794_CR138","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ni.1718","volume":"10","author":"T Gebhardt","year":"2009","unstructured":"Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR (2009) Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 10(5):524","journal-title":"Nat Immunol"},{"issue":"2","key":"794_CR139","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41385-018-0109-1","volume":"12","author":"N Bull","year":"2019","unstructured":"Bull N, Stylianou E, Kaveh D, Pinpathomrat N, Pasricha J, Harrington-Kandt R et al (2019) Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1\u2212 CD4+ T cells. Mucosal Immunol 12(2):555","journal-title":"Mucosal Immunol"},{"issue":"13","key":"794_CR140","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","volume":"18","author":"MA Sallin","year":"2017","unstructured":"Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, Barber DL (2017) Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis. Cell Rep 18(13):3091\u20133104","journal-title":"Cell Rep"},{"issue":"6","key":"794_CR141","doi-asserted-by":"publisher","first-page":"e01686","DOI":"10.1128\/mBio.01686-16","volume":"7","author":"C Perdomo","year":"2016","unstructured":"Perdomo C, Zedler U, K\u00fchl AA, Lozza L, Saikali P, Sander LE et al (2016) Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis. MBio. 7(6):e01686\u2013e01616","journal-title":"MBio."},{"issue":"2","key":"794_CR142","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/mi.2017.60","volume":"11","author":"KD Kauffman","year":"2018","unstructured":"Kauffman KD, Sallin MA, Sakai S, Kamenyeva O, Kabat J, Weiner D et al (2018) Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques. Mucosal Immunol 11(2):462","journal-title":"Mucosal Immunol"},{"issue":"7090","key":"794_CR143","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO et al (2006) Transforming growth factor-\u03b2 induces development of the T H 17 lineage. Nature. 441(7090):231","journal-title":"Nature."},{"issue":"2","key":"794_CR144","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24(2):179\u2013189","journal-title":"Immunity."},{"issue":"7090","key":"794_CR145","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector T H 17 and regulatory T cells. Nature. 441(7090):235","journal-title":"Nature."},{"issue":"2","key":"794_CR146","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233\u2013240","journal-title":"J Exp Med"},{"issue":"4","key":"794_CR147","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.194.4.519","volume":"194","author":"P Ye","year":"2001","unstructured":"Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4):519\u2013528","journal-title":"J Exp Med"},{"issue":"3","key":"794_CR148","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jaci.2006.12.643","volume":"119","author":"M Fujiwara","year":"2007","unstructured":"Fujiwara M, Hirose K, Kagami S-I, Takatori H, Wakashin H, Tamachi T et al (2007) T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J Allergy Clin Immunol 119(3):662\u2013670","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"794_CR149","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1073\/pnas.1035999100","volume":"100","author":"S Nakae","year":"2003","unstructured":"Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci 100(10):5986\u20135990","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"794_CR150","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171(11):6173\u20136177","journal-title":"J Immunol"},{"issue":"11","key":"794_CR151","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang Y-H et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133","journal-title":"Nat Immunol"},{"issue":"11","key":"794_CR152","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123","journal-title":"Nat Immunol"},{"issue":"3","key":"794_CR153","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","volume":"177","author":"A Cruz","year":"2006","unstructured":"Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J et al (2006) Cutting edge: IFN-\u03b3 regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177(3):1416\u20131420","journal-title":"J Immunol"},{"issue":"2","key":"794_CR154","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/eji.201141569","volume":"42","author":"R Gopal","year":"2012","unstructured":"Gopal R, Lin Y, Obermajer N, Slight S, Nuthalapati N, Ahmed M et al (2012) IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur J Immunol 42(2):364\u2013373","journal-title":"Eur J Immunol"},{"issue":"4","key":"794_CR155","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE et al (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8(4):369","journal-title":"Nat Immunol"},{"issue":"6","key":"794_CR156","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.4049\/jimmunol.1701424","volume":"200","author":"IY Nikitina","year":"2018","unstructured":"Nikitina IY, Panteleev AV, Kosmiadi GA, Serdyuk YV, Nenasheva TA, Nikolaev AA et al (2018) Th1, Th17, and Th1Th17 lymphocytes during tuberculosis: Th1 lymphocytes predominate and appear as low-differentiated CXCR3+ CCR6+ cells in the blood and highly differentiated CXCR3+\/\u2212 CCR6\u2212 cells in the lungs. J Immunol 200(6):2090\u20132103","journal-title":"J Immunol"},{"issue":"6","key":"794_CR157","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8(6):639","journal-title":"Nat Immunol"},{"issue":"5","key":"794_CR158","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/infdis\/jiv503","volume":"213","author":"N Aguilo","year":"2015","unstructured":"Aguilo N, Alvarez-Arguedas S, Uranga S, Marinova D, Monz\u00f3n M, Badiola J et al (2015) Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17\u2013dependent mechanism. J Infect Dis 213(5):831\u2013839","journal-title":"J Infect Dis"},{"issue":"8","key":"794_CR159","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","volume":"182","author":"Z Jaffar","year":"2009","unstructured":"Jaffar Z, Ferrini ME, Herritt LA, Roberts K (2009) Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol 182(8):4507\u20134511","journal-title":"J Immunol"},{"issue":"1","key":"794_CR160","doi-asserted-by":"publisher","first-page":"e16245","DOI":"10.1371\/journal.pone.0016245","volume":"6","author":"R Purwar","year":"2011","unstructured":"Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS (2011) Resident memory T cells (TRM) are abundant in human lung: diversity, function, and antigen specificity. PLoS One 6(1):e16245","journal-title":"PLoS One"},{"issue":"15","key":"794_CR161","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1073\/pnas.0308054101","volume":"101","author":"KM Huster","year":"2004","unstructured":"Huster KM, Busch V, Schiemann M, Linkemann K, Kerksiek KM, Wagner H et al (2004) Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci 101(15):5610\u20135615","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"794_CR162","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tube.2014.05.001","volume":"94","author":"M Henao-Tamayo","year":"2014","unstructured":"Henao-Tamayo M, Ordway DJ, Orme IM (2014) Memory T cell subsets in tuberculosis: what should we be targeting? Tuberculosis. 94(5):455\u2013461","journal-title":"Tuberculosis."},{"issue":"6754","key":"794_CR163","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401(6754):708","journal-title":"Nature."},{"issue":"4","key":"794_CR164","doi-asserted-by":"publisher","first-page":"e36046","DOI":"10.1371\/journal.pone.0036046","volume":"7","author":"T Adekambi","year":"2012","unstructured":"Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J (2012) Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One 7(4):e36046","journal-title":"PLoS One"},{"issue":"7","key":"794_CR165","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/infdis\/jis941","volume":"207","author":"AP Soares","year":"2013","unstructured":"Soares AP, Kwong Chung CK, Choice T, Hughes EJ, Jacobs G, van Rensburg EJ et al (2013) Longitudinal changes in CD4+ T-cell memory responses induced by BCG vaccination of newborns. J Infect Dis 207(7):1084\u20131094","journal-title":"J Infect Dis"},{"issue":"51","key":"794_CR166","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1016\/j.vaccine.2014.10.041","volume":"32","author":"DA Kaveh","year":"2014","unstructured":"Kaveh DA, Garcia-Pelayo MC, Hogarth PJ (2014) Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis. Vaccine. 32(51):6911\u20136918","journal-title":"Vaccine."},{"issue":"6","key":"794_CR167","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel JM, Masopust D (2014) Tissue-resident memory T cells. Immunity. 41(6):886\u2013897","journal-title":"Immunity."},{"issue":"11","key":"794_CR168","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","volume":"101","author":"J Geginat","year":"2003","unstructured":"Geginat J, Lanzavecchia A, Sallusto F (2003) Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 101(11):4260\u20134266","journal-title":"Blood."},{"issue":"1","key":"794_CR169","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4049\/jimmunol.1000492","volume":"185","author":"JJ Obar","year":"2010","unstructured":"Obar JJ, Lefran\u00e7ois L (2010) Early signals during CD8+ T cell priming regulate the generation of central memory cells. J Immunol 185(1):263\u2013272","journal-title":"J Immunol"},{"issue":"6","key":"794_CR170","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tube.2010.06.002","volume":"90","author":"IM Orme","year":"2010","unstructured":"Orme IM (2010) The Achilles heel of BCG. Tuberculosis. 90(6):329\u2013332","journal-title":"Tuberculosis."},{"issue":"9","key":"794_CR171","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/eji.200940279","volume":"40","author":"LM Connor","year":"2010","unstructured":"Connor LM, Harvie MC, Rich FJ, Quinn KM, Brinkmann V, Gros GL et al (2010) A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination. Eur J Immunol 40(9):2482\u20132492","journal-title":"Eur J Immunol"},{"issue":"2","key":"794_CR172","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.4473","volume":"24","author":"SG Hansen","year":"2018","unstructured":"Hansen SG, Zak DE, Xu G, Ford JC, Marshall EE, Malouli D et al (2018) Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine. Nat Med 24(2):130\u2013143","journal-title":"Nat Med"},{"issue":"6205","key":"794_CR173","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1254536","volume":"346","author":"JM Schenkel","year":"2014","unstructured":"Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D (2014) Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science. 346(6205):98\u2013101","journal-title":"Science."},{"issue":"3","key":"794_CR174","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41385-019-0145-5","volume":"12","author":"JS Woodworth","year":"2019","unstructured":"Woodworth JS, Christensen D, Cassidy JP, Agger EM, Mortensen R, Andersen P (2019) Mucosal boosting of H56: CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection. Mucosal Immunol 12(3):816","journal-title":"Mucosal Immunol"},{"issue":"2","key":"794_CR175","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm.2285","volume":"17","author":"C Aagaard","year":"2011","unstructured":"Aagaard C, Hoang T, Dietrich J, Cardona P-J, Izzo A, Dolganov G et al (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17(2):189","journal-title":"Nat Med"},{"issue":"2","key":"794_CR176","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","volume":"199","author":"S Suliman","year":"2019","unstructured":"Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z et al (2019) Dose optimization of H56: IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial. Am J Respir Crit Care Med 199(2):220\u2013231","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"794_CR177","doi-asserted-by":"publisher","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","volume":"4","author":"C Aagaard","year":"2009","unstructured":"Aagaard C, Hoang TTKT, Izzo A, Billeskov R, Troudt J, Arnett K et al (2009) Protection and polyfunctional T cells induced by Ag85B-TB10. 4\/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose. PLoS One 4(6):e5930","journal-title":"PLoS One"},{"issue":"4","key":"794_CR178","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/02770906809100348","volume":"5","author":"SR Rosenthal","year":"1968","unstructured":"Rosenthal SR, McEnery JT, Raisys N (1968) Aerogenic BCG vaccination against tuberculosis in animal and human subjects. J Asthma Res 5(4):309\u2013323","journal-title":"J Asthma Res"},{"issue":"9","key":"794_CR179","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","volume":"350","author":"M Mutsch","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T et al (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350(9):896\u2013903","journal-title":"N Engl J Med"},{"issue":"9","key":"794_CR180","doi-asserted-by":"publisher","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","volume":"4","author":"DJ Lewis","year":"2009","unstructured":"Lewis DJ, Huo Z, Barnett S, Kromann I, Giemza R, Galiza E et al (2009) Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One 4(9):e6999","journal-title":"PLoS One"},{"issue":"1568","key":"794_CR181","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/bmj.1.1568.125","volume":"1","author":"R Koch","year":"1891","unstructured":"Koch R (1891) A further communication on a remedy for tuberculosis. Br Med J 1(1568):125","journal-title":"Br Med J"},{"issue":"10","key":"794_CR182","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","volume":"14","author":"I Satti","year":"2014","unstructured":"Satti I, Meyer J, Harris SA, Thomas Z-RM, Griffiths K, Antrobus RD et al (2014) Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infect Dis 14(10):939\u2013946","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"794_CR183","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/rmv.612","volume":"19","author":"N Arnberg","year":"2009","unstructured":"Arnberg N (2009) Adenovirus receptors: implications for tropism, treatment and targeting. Rev Med Virol 19(3):165\u2013178","journal-title":"Rev Med Virol"},{"issue":"205","key":"794_CR184","doi-asserted-by":"publisher","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","volume":"5","author":"F Smaill","year":"2013","unstructured":"Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige-Don N, Zganiacz A et al (2013) A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med 5(205):205ra134\u2013205ra134","journal-title":"Sci Transl Med"},{"issue":"4","key":"794_CR185","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.vaccine.2019.10.102","volume":"38","author":"M Wilkie","year":"2020","unstructured":"Wilkie M, Satti I, Minhinnick A, Harris S, Riste M, Ramon RL et al (2020) A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime\u2014MVA85A boost in healthy UK adults. Vaccine. 38(4):779\u2013789","journal-title":"Vaccine."},{"issue":"4","key":"794_CR186","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.1400676","volume":"193","author":"PA Darrah","year":"2014","unstructured":"Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S et al (2014) Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge. J Immunol 193(4):1799\u20131811","journal-title":"J Immunol"},{"issue":"12","key":"794_CR187","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1073\/pnas.0800043105","volume":"105","author":"L Garcia-Contreras","year":"2008","unstructured":"Garcia-Contreras L, Wong Y-L, Muttil P, Padilla D, Sadoff J, DeRousse J et al (2008) Immunization by a bacterial aerosol. Proc Natl Acad Sci 105(12):4656\u20134660","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"794_CR188","first-page":"351","volume":"107","author":"WR Barclay","year":"1973","unstructured":"Barclay WR, Busey WM, Dalgard DW, Good RC, Janicki BW, Kasik JE et al (1973) Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis 107(3):351\u2013358","journal-title":"Am Rev Respir Dis"},{"issue":"8","key":"794_CR189","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1084\/jem.20102110","volume":"208","author":"JE Kohlmeier","year":"2011","unstructured":"Kohlmeier JE, Reiley WW, Perona-Wright G, Freeman ML, Yager EJ, Connor LM et al (2011) Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection. J Exp Med 208(8):1621\u20131634","journal-title":"J Exp Med"},{"issue":"2","key":"794_CR190","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","volume":"25","author":"K Dijkman","year":"2019","unstructured":"Dijkman K, Sombroek CC, Vervenne RAW, Hofman SO, Boot C, Remarque EJ et al (2019) Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques. Nat Med 25(2):255\u2013262","journal-title":"Nat Med"},{"issue":"11","key":"794_CR191","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1086\/516782","volume":"44","author":"M Brown","year":"2007","unstructured":"Brown M, Varia H, Bassett P, Davidson RN, Wall R, Pasvol G (2007) Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. Clin Infect Dis 44(11):1415\u20131420","journal-title":"Clin Infect Dis"},{"issue":"3","key":"794_CR192","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/trstmh\/tru206","volume":"109","author":"Z-R Manjaly Thomas","year":"2015","unstructured":"Manjaly Thomas Z-R, McShane H (2015) Aerosol immunisation for TB: matching route of vaccination to route of infection. Trans R Soc Trop Med Hyg 109(3):175\u2013181","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"794_CR193","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/IAI.00083-16","volume":"84","author":"J Phuah","year":"2016","unstructured":"Phuah J, Wong EA, Gideon HP, Maiello P, Coleman MT, Hendricks MR et al (2016) Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 84(5):1301\u20131311","journal-title":"Infect Immun"},{"issue":"5","key":"794_CR194","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S et al (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209(5):1001\u20131010","journal-title":"J Exp Med"},{"issue":"10","key":"794_CR195","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3(10):944","journal-title":"Nat Immunol"},{"issue":"12","key":"794_CR196","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","volume":"8","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T et al (2007) TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T H-17 cell-mediated pathology. Nat Immunol 8(12):1390","journal-title":"Nat Immunol"},{"issue":"2","key":"794_CR197","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cyto.2015.01.009","volume":"73","author":"SJ Ireland","year":"2015","unstructured":"Ireland SJ, Monson NL, Davis LS (2015) Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine. 73(2):236\u2013244","journal-title":"Cytokine."},{"issue":"1","key":"794_CR198","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-2249.1996.d01-643.x","volume":"104","author":"B Nikonenko","year":"1996","unstructured":"Nikonenko B, Apt A, Mezhlumova M, Avdienko V, Yeremeev V, Moroz A (1996) Influence of the mouse BcgTbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette\u2013Gu\u00e9rin (BCG) vaccination. Clin Exp Immunol 104(1):37\u201343","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"794_CR199","doi-asserted-by":"publisher","first-page":"e1003472","DOI":"10.1371\/journal.ppat.1003472","volume":"9","author":"L Kozakiewicz","year":"2013","unstructured":"Kozakiewicz L, Chen Y, Xu J, Wang Y, Dunussi-Joannopoulos K, Ou Q et al (2013) B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog 9(7):e1003472","journal-title":"PLoS Pathog"},{"issue":"3","key":"794_CR200","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.4049\/jimmunol.0902011","volume":"184","author":"TK Kondratieva","year":"2010","unstructured":"Kondratieva TK, Rubakova EI, Linge IA, Evstifeev VV, Majorov KB, Apt AS (2010) B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis infection in mice. J Immunol 184(3):1227\u20131234","journal-title":"J Immunol"},{"issue":"3","key":"794_CR201","doi-asserted-by":"publisher","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","volume":"12","author":"AE Mahan","year":"2016","unstructured":"Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW et al (2016) Antigen-specific antibody glycosylation is regulated via vaccination. PLoS Pathog 12(3):e1005456","journal-title":"PLoS Pathog"},{"issue":"2","key":"794_CR202","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.170.2.481","volume":"170","author":"JV Ravetch","year":"1989","unstructured":"Ravetch JV, Perussia B (1989) Alternative membrane forms of Fc gamma RIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 170(2):481\u2013497","journal-title":"J Exp Med"},{"issue":"11","key":"794_CR203","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","volume":"8","author":"N Zimmermann","year":"2016","unstructured":"Zimmermann N, Thormann V, Hu B, K\u00f6hler AB, Imai-Matsushima A, Locht C et al (2016) Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis. EMBO Molecular Medicine 8(11):1325\u20131339","journal-title":"EMBO Molecular Medicine"},{"issue":"19","key":"794_CR204","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114","volume":"114","author":"H Li","year":"2017","unstructured":"Li H, Wang X-X, Wang B, Fu L, Liu G, Lu Y et al (2017) Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis. Proc Natl Acad Sci 114(19):5023\u20135028","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"794_CR205","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","volume":"180","author":"PJ Maglione","year":"2008","unstructured":"Maglione PJ, Xu J, Casadevall A, Chan J (2008) Fc\u03b3 receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J Immunol 180(5):3329\u20133338","journal-title":"J Immunol"},{"issue":"3","key":"794_CR206","doi-asserted-by":"publisher","first-page":"e1000794","DOI":"10.1371\/journal.ppat.1000794","volume":"6","author":"M Sani","year":"2010","unstructured":"Sani M, Houben EN, Geurtsen J, Pierson J, De Punder K, van Zon M et al (2010) Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog 6(3):e1000794","journal-title":"PLoS Pathog"},{"issue":"3","key":"794_CR207","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/infdis\/jiw153","volume":"214","author":"R Prados-Rosales","year":"2016","unstructured":"Prados-Rosales R, Carre\u00f1o LJ, Weinrick B, Batista-Gonzalez A, Glatman-Freedman A, Xu J et al (2016) The type of growth medium affects the presence of a mycobacterial capsule and is associated with differences in protective efficacy of BCG vaccination against Mycobacterium tuberculosis. J Infect Dis 214(3):426\u2013437","journal-title":"J Infect Dis"},{"issue":"3","key":"794_CR208","doi-asserted-by":"publisher","first-page":"e1006250","DOI":"10.1371\/journal.ppat.1006250","volume":"13","author":"R Prados-Rosales","year":"2017","unstructured":"Prados-Rosales R, Carre\u00f1o L, Cheng T, Blanc C, Weinrick B, Malek A et al (2017) Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog 13(3):e1006250","journal-title":"PLoS Pathog"},{"issue":"10","key":"794_CR209","doi-asserted-by":"publisher","first-page":"e0185945","DOI":"10.1371\/journal.pone.0185945","volume":"12","author":"H-J Shin","year":"2017","unstructured":"Shin H-J, Franco LH, Nair VR, Collins AC, Shiloh MU (2017) A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan. PLoS One 12(10):e0185945","journal-title":"PLoS One"},{"issue":"9","key":"794_CR210","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1086\/522428","volume":"196","author":"L Qin","year":"2007","unstructured":"Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG (2007) A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis 196(9):1304\u20131312","journal-title":"J Infect Dis"},{"issue":"3","key":"794_CR211","doi-asserted-by":"publisher","first-page":"e1007643","DOI":"10.1371\/journal.ppat.1007643","volume":"15","author":"MJ Rodo","year":"2019","unstructured":"Rodo MJ, Rozot V, Nemes E, Dintwe O, Hatherill M, Little F et al (2019) A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog 15(3):e1007643","journal-title":"PLoS Pathog"},{"issue":"4","key":"794_CR212","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Schrager L (2016) TB vaccine development and the end TB strategy: importance and current status. Trans R Soc Trop Med Hyg 110(4):212\u2013218","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"794_CR213","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/resp.13245","volume":"23","author":"B Zhu","year":"2018","unstructured":"Zhu B, Dockrell HM, Ottenhoff TH, Evans TG, Zhang Y (2018) Tuberculosis vaccines: opportunities and challenges. Respirology. 23(4):359\u2013368","journal-title":"Respirology."},{"issue":"2","key":"794_CR214","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N et al (2018) Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination. N Engl J Med 379(2):138\u2013149","journal-title":"N Engl J Med"},{"issue":"4","key":"794_CR215","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","volume":"71","author":"MA Horwitz","year":"2003","unstructured":"Horwitz MA, Harth G (2003) A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71(4):1672\u20131679","journal-title":"Infect Immun"},{"issue":"10","key":"794_CR216","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1086\/592450","volume":"198","author":"DF Hoft","year":"2008","unstructured":"Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, Soler JH et al (2008) A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198(10):1491\u20131501","journal-title":"J Infect Dis"},{"issue":"2","key":"794_CR217","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.molimm.2015.04.003","volume":"66","author":"G Li","year":"2015","unstructured":"Li G, Liu G, Song N, Kong C, Huang Q, Su H et al (2015) A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice. Mol Immunol 66(2):346\u2013356","journal-title":"Mol Immunol"},{"key":"794_CR218","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ebiom.2016.04.010","volume":"7","author":"DF Hoft","year":"2016","unstructured":"Hoft DF, Blazevic A, Selimovic A, Turan A, Tennant J, Abate G et al (2016) Safety and immunogenicity of the recombinant BCG vaccine AERAS-422 in healthy BCG-na\u00efve adults: a randomized, active-controlled, first-in-human phase 1 trial. EBioMedicine. 7:278\u2013286","journal-title":"EBioMedicine."},{"issue":"42","key":"794_CR219","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","volume":"31","author":"A Arbues","year":"2013","unstructured":"Arbues A, Aguilo JI, Gonzalo-Asensio J, Marinova D, Uranga S, Puentes E et al (2013) Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. Vaccine. 31(42):4867\u20134873","journal-title":"Vaccine."},{"issue":"2","key":"794_CR220","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1371\/journal.ppat.0040033","volume":"4","author":"W Frigui","year":"2008","unstructured":"Frigui W, Bottai D, Majlessi L, Monot M, Josselin E, Brodin P et al (2008) Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog 4(2):e33","journal-title":"PLoS Pathog"},{"issue":"2","key":"794_CR221","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2958.2006.05102.x","volume":"60","author":"SB Walters","year":"2006","unstructured":"Walters SB, Dubnau E, Kolesnikova I, Laval F, Daffe M, Smith I (2006) The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol Microbiol 60(2):312\u2013330","journal-title":"Mol Microbiol"},{"issue":"2","key":"794_CR222","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2958.1999.01593.x","volume":"34","author":"LR Camacho","year":"1999","unstructured":"Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C (1999) Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34(2):257\u2013267","journal-title":"Mol Microbiol"},{"issue":"6757","key":"794_CR223","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/47042","volume":"402","author":"JS Cox","year":"1999","unstructured":"Cox JS, Chen B, McNeil M, Jacobs WR Jr (1999) Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature. 402(6757):79","journal-title":"Nature."},{"issue":"9","key":"794_CR224","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S2213-2600(19)30251-6","volume":"7","author":"M Tameris","year":"2019","unstructured":"Tameris M, Mearns H, Penn-Nicholson A, Gregg Y, Bilek N, Mabwe S et al (2019) Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial. Lancet Respir Med 7(9):757\u2013770","journal-title":"Lancet Respir Med"},{"issue":"1","key":"794_CR225","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-8518-9-3","volume":"9","author":"DA Butov","year":"2011","unstructured":"Butov DA, Pashkov YN, Stepanenko AL, Choporova AI, Butova TS, Batdelger D et al (2011) Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB. J Immune Based Ther Vaccines 9(1):3","journal-title":"J Immune Based Ther Vaccines"},{"issue":"5","key":"794_CR226","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","volume":"24","author":"CF von Reyn","year":"2010","unstructured":"von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T et al (2010) Prevention of tuberculosis in bacille Calmette\u2013Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. Aids. 24(5):675\u2013685","journal-title":"Aids."},{"issue":"1","key":"794_CR227","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mjafi.2018.12.013","volume":"75","author":"J Soundarya","year":"2019","unstructured":"Soundarya J, Ranganathan UD, Tripathy SP (2019) Current trends in tuberculosis vaccine. Med J Armed Forces India 75(1):18\u201324","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"794_CR228","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1038\/s41598-017-03514-1","volume":"7","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Katoch K, Sarin R, Balambal R, Jain NK, Patel N et al (2017) Efficacy and safety of Mycobacterium indicus pranii as an adjunct therapy in category II pulmonary tuberculosis in a randomized trial. Sci Rep 7(1):3354","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"794_CR229","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","volume":"86","author":"P-J Cardona","year":"2006","unstructured":"Cardona P-J (2006) RUTI: a new chance to shorten the treatment of latent tuberculosis infection. Tuberculosis. 86(3\u20134):273\u2013289","journal-title":"Tuberculosis."},{"issue":"5\u20136","key":"794_CR230","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","volume":"7","author":"H McShane","year":"2005","unstructured":"McShane H, Hill A (2005) Prime-boost immunisation strategies for tuberculosis. Microbes Infect 7(5\u20136):962\u2013967","journal-title":"Microbes Infect"},{"issue":"8","key":"794_CR231","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","volume":"35","author":"P Andersen","year":"2014","unstructured":"Andersen P, Woodworth JS (2014) Tuberculosis vaccines\u2014rethinking the current paradigm. Trends Immunol 35(8):387\u2013395","journal-title":"Trends Immunol"},{"issue":"12","key":"794_CR232","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","volume":"182","author":"T Lindenstr\u00f8m","year":"2009","unstructured":"Lindenstr\u00f8m T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA et al (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 182(12):8047\u20138055","journal-title":"J Immunol"},{"issue":"17","key":"794_CR233","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","volume":"379","author":"O Van Der Meeren","year":"2018","unstructured":"Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E et al (2018) Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 379(17):1621\u20131634","journal-title":"N Engl J Med"},{"issue":"7","key":"794_CR234","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1073\/pnas.0712077106","volume":"106","author":"SG Reed","year":"2009","unstructured":"Reed SG, Coler RN, Dalemans W, Tan EV, DeLa Cruz EC, Basaraba RJ et al (2009) Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci U S A 106(7):2301\u20132306","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"794_CR235","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","volume":"72","author":"L Brandt","year":"2004","unstructured":"Brandt L, Skeiky YA, Alderson MR, Lobet Y, Dalemans W, Turner OC et al (2004) The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun 72(11):6622\u20136632","journal-title":"Infect Immun"},{"issue":"53","key":"794_CR236","doi-asserted-by":"publisher","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","volume":"2","author":"S Bertholet","year":"2010","unstructured":"Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, Kahn M et al (2010) A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med 2(53):53ra74\u201353ra74","journal-title":"Sci Transl Med"},{"issue":"1","key":"794_CR237","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.colsurfb.2009.08.022","volume":"75","author":"RC Anderson","year":"2010","unstructured":"Anderson RC, Fox CB, Dutill TS, Shaverdian N, Evers TL, Poshusta GR et al (2010) Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations. Colloids Surf B: Biointerfaces 75(1):123\u2013132","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"4","key":"794_CR238","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","volume":"6","author":"A Penn-Nicholson","year":"2018","unstructured":"Penn-Nicholson A, Tameris M, Smit E, Day TA, Musvosvi M, Jayashankar L et al (2018) Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Lancet Respir Med 6(4):287\u2013298","journal-title":"Lancet Respir Med"},{"issue":"11","key":"794_CR239","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/nm1128","volume":"10","author":"H McShane","year":"2004","unstructured":"McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K et al (2004) Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10(11):1240","journal-title":"Nat Med"},{"issue":"12","key":"794_CR240","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/infdis\/jir195","volume":"203","author":"TJ Scriba","year":"2011","unstructured":"Scriba TJ, Tameris M, Mansoor N, Smit E, van der Merwe L, Mauff K et al (2011) Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. J Infect Dis 203(12):1832\u20131843","journal-title":"J Infect Dis"},{"key":"794_CR241","doi-asserted-by":"publisher","first-page":"11290","DOI":"10.1038\/ncomms11290","volume":"7","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA et al (2016) T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun 7:11290","journal-title":"Nat Commun"},{"issue":"4","key":"794_CR242","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.4049\/jimmunol.1100560","volume":"187","author":"L \u010ci\u010din-\u0160ain","year":"2011","unstructured":"\u010ci\u010din-\u0160ain L, Sylwester AW, Hagen SI, Siess DC, Currier N, Legasse AW et al (2011) Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. J Immunol 187(4):1722\u20131732","journal-title":"J Immunol"},{"key":"794_CR243","first-page":"450","volume":"2","author":"MA Jarvis","year":"2013","unstructured":"Jarvis MA, Hansen SG, Nelson JA, Picker LJ, Fruh K (2013) Vaccine vectors using the unique biology and immunology of cytomegalovirus. Cytomegaloviruses: from Molecular Pathogenesis to Intervention 2:450\u2013463","journal-title":"Cytomegaloviruses: from Molecular Pathogenesis to Intervention"},{"issue":"6274","key":"794_CR244","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1126\/science.aac9475","volume":"351","author":"SG Hansen","year":"2016","unstructured":"Hansen SG, Wu HL, Burwitz BJ, Hughes CM, Hammond KB, Ventura AB et al (2016) Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E. Science. 351(6274):714\u2013720","journal-title":"Science."},{"issue":"1","key":"794_CR245","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0010005","volume":"1","author":"MC Gutierrez","year":"2005","unstructured":"Gutierrez MC, Brisse S, Brosch R, Fabre M, Oma\u00efs B, Marmiesse M et al (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1(1):e5","journal-title":"PLoS Pathog"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-020-00794-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T20:24:54Z","timestamp":1695932694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-020-00794-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":245,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s00281-020-00794-0","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}